Teresia Nyambura Wacira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Teresia Nyambura Wacira has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Huxley Mae Makonde
Department of Pure and Applied Sciences, Technical University of Mombasa, Mombasa, Kenya
4 shared publications - Cromwell Mwiti Kibiti
Department of Pure and Applied Sciences, Technical University of Mombasa, Mombasa, Kenya
3 shared publications - Christopher Mulanda Aura
Kenya Marine and Fisheries Research Institute Kisumu Kenya
2 shared publications - Benjamin Wesonga Panyako
Kenyatta University
1 shared publication - Caleb Ogwai
Kenya Marine and Fisheries Research Institute Kisumu Kenya
1 shared publication - Carren Bosire
Department of Pure and Applied Sciences, Technical University of Mombasa, Mombasa 80100, Kenya
1 shared publication
Latest Publications
- Open Access
- 24 July 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (7) , e0325642
Characterization and bioactivity potential of marine sponges (Biemna fistulosa, Callyspongia diffusa, and Haliclona fascigera) from Kenyan coastal waters
Sponges have been reported as a rich source of bioactive compounds, which could potentially be developed into lead compounds for pharmaceutical use. The present study aimed to identify sponges and assess the biological activity of their extracts against human disease-causing organisms, including Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans. Morphological characterization and DNA barcoding of the cytochrome c oxidase subunit I (COI) gene characterized three sponge species (Biemna fistulosa, Callyspongia diffusa and Haliclona fascigera). The Kirby-Bauer test assessed the antimicrobial activity of the extracts, and the inhibition zone diameters (IZD) were measured. The extracts were further subjected to minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests to determine the antibiotic susceptibility. The Gas Chromatography-Mass Spectrometry (GC-MS) was used to identify and quantify the organic compounds in the sponges’ extracts. The methanolic extract of B. fistulosa (28.00 ± 3.5 mm) and H. fascigera. (28.33 ± 3.8 mm) exhibited a broad spectrum of antibacterial activity against E. coli, surpassing the positive control (27.67 ± 0.9 mm). The inhibitory activity of ethyl acetate extract of the C. diffusa (29.33 ± 2.4 mm) against P. aeruginosa was observed to be higher compared to the standard antibiotic streptomycin (26.67 ± 0.7 mm). The methanolic extract of H. fascigera demonstrated the lowest MIC (0.53 ± 0.0 mg mL-1) compared to the streptomycin drug (1.36 ± 0.0 mg mL-1), and showed an MBC of 1.25 mg mL-1 against E. coli. The GC-MS chromatogram data analysis identified 114 distinct compounds categorized into 39 classes across three sponge extracts: 11.4% of these compounds demonstrated documented antimicrobial activity against human pathogens. This study corroborates sponges as a promising source of bioactive compounds, which are valuable leads for drug discovery and development. Future research must explore their mechanisms, molecular-level toxicity, and lead optimization to enhance drug development.
- 24 July 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (7) , e0325642
Open AccessCharacterization and bioactivity potential of marine sponges (Biemna fistulosa, Callyspongia diffusa, and Haliclona fascigera) from Kenyan coastal waters
Sponges have been reported as a rich source of bioactive compounds, which could potentially be developed into lead compounds for pharmaceutical use. The present study aimed to identify sponges and assess the biological activity of their extracts against human disease-causing organisms, including Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans. Morphological characterization and DNA barcoding of the cytochrome c oxidase subunit I (COI) gene characterized three sponge species (Biemna fistulosa, Callyspongia diffusa and Haliclona fascigera). The Kirby-Bauer test assessed the antimicrobial activity of the extracts, and the inhibition zone diameters (IZD) were measured. The extracts were further subjected to minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests to determine the antibiotic susceptibility. The Gas Chromatography-Mass Spectrometry (GC-MS) was used to identify and quantify the organic compounds in the sponges’ extracts. The methanolic extract of B. fistulosa (28.00 ± 3.5 mm) and H. fascigera. (28.33 ± 3.8 mm) exhibited a broad spectrum of antibacterial activity against E. coli, surpassing the positive control (27.67 ± 0.9 mm). The inhibitory activity of ethyl acetate extract of the C. diffusa (29.33 ± 2.4 mm) against P. aeruginosa was observed to be higher compared to the standard antibiotic streptomycin (26.67 ± 0.7 mm). The methanolic extract of H. fascigera demonstrated the lowest MIC (0.53 ± 0.0 mg mL-1) compared to the streptomycin drug (1.36 ± 0.0 mg mL-1), and showed an MBC of 1.25 mg mL-1 against E. coli. The GC-MS chromatogram data analysis identified 114 distinct compounds categorized into 39 classes across three sponge extracts: 11.4% of these compounds demonstrated documented antimicrobial activity against human pathogens. This study corroborates sponges as a promising source of bioactive compounds, which are valuable leads for drug discovery and development. Future research must explore their mechanisms, molecular-level toxicity, and lead optimization to enhance drug development.
- 14 July 2025
- Published by Wiley in Journal of Fish Diseases
- Vol. 49 (1) , e70022
Disease and Antimicrobial Resistance Surveillance for Nile Tilapia Pathogens in Lake Victoria, Kenya
The cage aquaculture industry in Lake Victoria, Kenya is growing explosively to meet increasing demand for fish, yet large‐scale fish mortalities are prevalent and pose economic shocks with catastrophic livelihood impacts. To gain a more comprehensive understanding of fish health in Lake Victoria, our study applied: (1) survey of cage farmer accounts, perceptions and responses to fish kill events; (2) rapid‐response investigation to a significant tilapia mortality event; (3) active disease surveillance; and (4) antimicrobial resistance (AMR) testing of bacterial pathogens via disk diffusion. There were 82 fish kills recalled from 2020 to 2023 with total mortalities exceeding 1.8 million tilapia; yet, only 39% of farmers reported to Kenyan institutions and 17% of farmers attempted medical treatment. Low dissolved oxygen (DO) levels and the isolation of Aeromonas jandaei , Enterobacter hormaechei and Staphylococcus epidermidis were implicated as suspected causes for a recent tilapia mortality event. Active disease surveillance detected trichodinids and monogeneans as common external parasites and identified an additional six bacterial species in tilapia ( Acinetobacter soli , Bacillus cereus , Kocuria rhizophila , Micrococcus luteus , Plesiomonas shigelloides , Staphylococcus sciuri ) previously published as fish pathogens. Furthermore, we identify AMR patterns that will support the development of host‐ and pathogen‐specific thresholds.
- 14 July 2025
- Published by Wiley in Journal of Fish Diseases
- Vol. 49 (1) , e70022
Disease and Antimicrobial Resistance Surveillance for Nile Tilapia Pathogens in Lake Victoria, Kenya
The cage aquaculture industry in Lake Victoria, Kenya is growing explosively to meet increasing demand for fish, yet large‐scale fish mortalities are prevalent and pose economic shocks with catastrophic livelihood impacts. To gain a more comprehensive understanding of fish health in Lake Victoria, our study applied: (1) survey of cage farmer accounts, perceptions and responses to fish kill events; (2) rapid‐response investigation to a significant tilapia mortality event; (3) active disease surveillance; and (4) antimicrobial resistance (AMR) testing of bacterial pathogens via disk diffusion. There were 82 fish kills recalled from 2020 to 2023 with total mortalities exceeding 1.8 million tilapia; yet, only 39% of farmers reported to Kenyan institutions and 17% of farmers attempted medical treatment. Low dissolved oxygen (DO) levels and the isolation of Aeromonas jandaei , Enterobacter hormaechei and Staphylococcus epidermidis were implicated as suspected causes for a recent tilapia mortality event. Active disease surveillance detected trichodinids and monogeneans as common external parasites and identified an additional six bacterial species in tilapia ( Acinetobacter soli , Bacillus cereus , Kocuria rhizophila , Micrococcus luteus , Plesiomonas shigelloides , Staphylococcus sciuri ) previously published as fish pathogens. Furthermore, we identify AMR patterns that will support the development of host‐ and pathogen‐specific thresholds.
- Open Access
Characterization and Bioactivity Potential of Marine Sponges (Biemna fistulosa, Callyspongia diffusa, and Haliclona fascigera) from Kenyan Coastal Waters
Sponges have been reported as a rich source of bioactive compounds, which could potentially be developed into lead compounds for pharmaceutical use. The present study aimed to identify sponges and assess the biological activity of their extracts against human disease-causing organisms, including Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans. Morphological characterization and DNA barcoding of the cytochrome c oxidase subunit I (COI) gene characterized three sponge species (Biemna fistulosa, Callyspongia diffusa and Haliclona fascigera). The Kirby-Bauer test assessed the antimicrobial activity of the extracts and the inhibition zone diameters (IZD) were measured. The extracts were further subjected to minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests to determine the antibiotic susceptibility. The Gas Chromatography-Mass Spectrometry (GC-MS) was used to identify and quantify the organic compounds in the sponges’ extracts. The methanolic extract of B. fistulosa (28.00 ± 3.5 mm) and H. fascigera. (28.33 ± 3.8 mm) exhibited a broad spectrum of antibacterial activity against E. coli surpassing the positive control (27.67 ± 0.9 mm). The inhibitory activity of ethyl acetate extract of the C. diffusa (29.33 ± 2.4 mm) against P. aeruginosa was observed to be higher compared to the standard antibiotic streptomycin (26.67±0.7 mm). The methanolic extract of H. fascigera demonstrated the lowest MIC (0.53 ± 0.0 mg/ml) in compared to the streptomycin drug (1.36 ± 0.0 mg/ml), and showed an MBC of 1.25 mg/ml against E. coli. The GC-MS chromatogram data analysis identified 114 distinct compounds categorized into 39 classes across three sponge extracts, with 11.4% of these compounds demonstrating documented antimicrobial activity against human pathogens. This study corroborates sponges as a promising source of bioactive compounds, which are valuable leads for drug discovery and development. Future research must explore their mechanisms, molecular-level toxicity, and lead optimization to enhance drug development.
Open AccessCharacterization and Bioactivity Potential of Marine Sponges (Biemna fistulosa, Callyspongia diffusa, and Haliclona fascigera) from Kenyan Coastal Waters
Sponges have been reported as a rich source of bioactive compounds, which could potentially be developed into lead compounds for pharmaceutical use. The present study aimed to identify sponges and assess the biological activity of their extracts against human disease-causing organisms, including Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans. Morphological characterization and DNA barcoding of the cytochrome c oxidase subunit I (COI) gene characterized three sponge species (Biemna fistulosa, Callyspongia diffusa and Haliclona fascigera). The Kirby-Bauer test assessed the antimicrobial activity of the extracts and the inhibition zone diameters (IZD) were measured. The extracts were further subjected to minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests to determine the antibiotic susceptibility. The Gas Chromatography-Mass Spectrometry (GC-MS) was used to identify and quantify the organic compounds in the sponges’ extracts. The methanolic extract of B. fistulosa (28.00 ± 3.5 mm) and H. fascigera. (28.33 ± 3.8 mm) exhibited a broad spectrum of antibacterial activity against E. coli surpassing the positive control (27.67 ± 0.9 mm). The inhibitory activity of ethyl acetate extract of the C. diffusa (29.33 ± 2.4 mm) against P. aeruginosa was observed to be higher compared to the standard antibiotic streptomycin (26.67±0.7 mm). The methanolic extract of H. fascigera demonstrated the lowest MIC (0.53 ± 0.0 mg/ml) in compared to the streptomycin drug (1.36 ± 0.0 mg/ml), and showed an MBC of 1.25 mg/ml against E. coli. The GC-MS chromatogram data analysis identified 114 distinct compounds categorized into 39 classes across three sponge extracts, with 11.4% of these compounds demonstrating documented antimicrobial activity against human pathogens. This study corroborates sponges as a promising source of bioactive compounds, which are valuable leads for drug discovery and development. Future research must explore their mechanisms, molecular-level toxicity, and lead optimization to enhance drug development.
- Open Access
- 1 January 2025
- Published by Wiley in International Journal of Microbiology
- Vol. 2025 (1)
Identification and Antimicrobial Potential of Marine Sponges ( Carteriospongia foliascens , Callyspongia fallax , and Paratetilla arcifera ) from Kenyan Marine Waters
Emerging and re‐emerging infectious diseases and pathogens present a significant global public health threat that has led researchers to focus on discovering new antimicrobial agents in order to address the challenge. Sponges are a promising source of marine natural products, which can be used as lead molecules for drug discovery. This study was aimed at identifying marine sponges through morphological and molecular techniques and evaluate the bioactivity potential of their organic crude extracts against Escherichia coli , Staphylococcus aureus , Pseudomonas aeruginosa , and Candida albicans. Deoxyribonucleic acid (DNA) barcoding of the cytochrome c oxidase subunit I (COI) gene identified three genera of sponges ( Carteriospongia , Callyspongia , and Paratetilla ). Disk diffusion assay was used to determine the inhibition zone diameter (IZD) of the sponges’ extracts. Minimum inhibitory concentrations (MICs) and the minimum bactericidal/fungicidal concentrations (MBCs/MFCs) of the most active sponge extracts were determined. The bioactive compounds were analyzed using gas chromatography–mass spectrometry (GC‐MS). The dichloromethane extracts of Carteriospongia foliascens demonstrated the highest antifungal activity against C. albicans (31.33 ± 1.2 mg mL −1 ), surpassing the standard drug fluconazole (29.33 ± 1.5 mg mL −1 ). The MIC values for the sponge extracts ranged from 3.86 to 5.89 mg mL −1 , and the ethyl acetate extract of Callyspongia fallax had an MBC of 4.03 mg mL −1 against S. aureus . GC‐MS chromatogram identified 98 compounds across 41 classes in three sponge extracts. Notably, 9.2% of these compounds have been reported to exhibit antimicrobial activity against human pathogens. This study confirms that sponges are a source of useful biochemicals, which have potential for drug discovery. To the best of our knowledge, this is the first comprehensive study to report on the characterization of marine sponges from the Kenyan waters. Further research work to structurally elucidate and identify the most active bioactive compounds from the extracts of C. foliascens and C. fallax is recommended.
- 1 January 2025
- Published by Wiley in International Journal of Microbiology
- Vol. 2025 (1)
Open AccessIdentification and Antimicrobial Potential of Marine Sponges ( Carteriospongia foliascens , Callyspongia fallax , and Paratetilla arcifera ) from Kenyan Marine Waters
Emerging and re‐emerging infectious diseases and pathogens present a significant global public health threat that has led researchers to focus on discovering new antimicrobial agents in order to address the challenge. Sponges are a promising source of marine natural products, which can be used as lead molecules for drug discovery. This study was aimed at identifying marine sponges through morphological and molecular techniques and evaluate the bioactivity potential of their organic crude extracts against Escherichia coli , Staphylococcus aureus , Pseudomonas aeruginosa , and Candida albicans. Deoxyribonucleic acid (DNA) barcoding of the cytochrome c oxidase subunit I (COI) gene identified three genera of sponges ( Carteriospongia , Callyspongia , and Paratetilla ). Disk diffusion assay was used to determine the inhibition zone diameter (IZD) of the sponges’ extracts. Minimum inhibitory concentrations (MICs) and the minimum bactericidal/fungicidal concentrations (MBCs/MFCs) of the most active sponge extracts were determined. The bioactive compounds were analyzed using gas chromatography–mass spectrometry (GC‐MS). The dichloromethane extracts of Carteriospongia foliascens demonstrated the highest antifungal activity against C. albicans (31.33 ± 1.2 mg mL −1 ), surpassing the standard drug fluconazole (29.33 ± 1.5 mg mL −1 ). The MIC values for the sponge extracts ranged from 3.86 to 5.89 mg mL −1 , and the ethyl acetate extract of Callyspongia fallax had an MBC of 4.03 mg mL −1 against S. aureus . GC‐MS chromatogram identified 98 compounds across 41 classes in three sponge extracts. Notably, 9.2% of these compounds have been reported to exhibit antimicrobial activity against human pathogens. This study confirms that sponges are a source of useful biochemicals, which have potential for drug discovery. To the best of our knowledge, this is the first comprehensive study to report on the characterization of marine sponges from the Kenyan waters. Further research work to structurally elucidate and identify the most active bioactive compounds from the extracts of C. foliascens and C. fallax is recommended.
- Open Access
- 11 March 2024
- Published by Springer Nature in Research Square
Bioremediation Potential of Soil Lead (Pb) Tolerant Fungi isolated from Owino Uhuru, a Suburb of Mombasa County, Kenya
A lead (Pb) smelter plant located in Owino Uhuru, a suburb of Mombasa County, caused lead poisoning and lifelong health effects. The Government of Kenya closed down the plant after reports of contamination. This study collected 24 soil samples from Owino Uhuru and analyzed them for lead levels using Microplasma Atomic Emission Spectrometry. The study also isolated and identified seven strains of fungi from the lead-contaminated soil and screened them for their ability to absorb lead. The genomic DNA of the fungal isolates was identified using ITS sequences of the rDNA. Blastn analysis indicated that the ITS gene sequences of the isolates had similarities of > 100% with known sequences in the nucleotide sequence database. These fungi were identified as Aspergillus welwitschiae, Aspergillus oryzae, Aspergillus piperis, Aspergillus austwickii, Aspergillus aflatoxiformans and Aspergillus tubingensis. The fungal isolates were tested for their ability to absorb lead at concentrations of 1.0 ppm, 0.8 ppm, 0.6 ppm, 0.4 ppm, and 0.2 ppm. The soil sample closest to the battery recycling plant contained more lead than those collected further away. Soil sample AU06, taken from the area bordering the wall of the lead smelter plant, had the highest lead concentration compared to all the samples. Aspergillus welwitschiae (GRY1) showed a higher potential for lead biosorption of 0.35 ± 0.1 ppm at 0.6 ppm lead concentration compared to other Aspergillus species. The study suggests using these fungal isolates for the removal and bio-treatment of lead-contaminated and polluted environments.
- 11 March 2024
- Published by Springer Nature in Research Square
Open AccessBioremediation Potential of Soil Lead (Pb) Tolerant Fungi isolated from Owino Uhuru, a Suburb of Mombasa County, Kenya
A lead (Pb) smelter plant located in Owino Uhuru, a suburb of Mombasa County, caused lead poisoning and lifelong health effects. The Government of Kenya closed down the plant after reports of contamination. This study collected 24 soil samples from Owino Uhuru and analyzed them for lead levels using Microplasma Atomic Emission Spectrometry. The study also isolated and identified seven strains of fungi from the lead-contaminated soil and screened them for their ability to absorb lead. The genomic DNA of the fungal isolates was identified using ITS sequences of the rDNA. Blastn analysis indicated that the ITS gene sequences of the isolates had similarities of > 100% with known sequences in the nucleotide sequence database. These fungi were identified as Aspergillus welwitschiae, Aspergillus oryzae, Aspergillus piperis, Aspergillus austwickii, Aspergillus aflatoxiformans and Aspergillus tubingensis. The fungal isolates were tested for their ability to absorb lead at concentrations of 1.0 ppm, 0.8 ppm, 0.6 ppm, 0.4 ppm, and 0.2 ppm. The soil sample closest to the battery recycling plant contained more lead than those collected further away. Soil sample AU06, taken from the area bordering the wall of the lead smelter plant, had the highest lead concentration compared to all the samples. Aspergillus welwitschiae (GRY1) showed a higher potential for lead biosorption of 0.35 ± 0.1 ppm at 0.6 ppm lead concentration compared to other Aspergillus species. The study suggests using these fungal isolates for the removal and bio-treatment of lead-contaminated and polluted environments.
- Open Access
- 1 January 2024
- Published by Wiley in International Journal of Microbiology
- Vol. 2024 (1) , 1261721
Molecular Characterization and Antibacterial Potential of Endophytic Fungal Isolates from Selected Mangroves along the Coastline of Kenya
The increasing emergence and re‐emergence of resistant pathogenic microbes causes a health threat to the human population. Scientists have been striving to find novel bioactive compounds and drugs to overcome these obstacles. This study aimed to characterize mangrove endophytic fungi and evaluate their antibacterial activity. Heritiera littoralis, Rhizophora mucronata, Bruguiera gymnorrhiza, Avicennia marina, and Xylocarpus granatum species were collected from Tudor Creek, Mida Creek, and Gazi Bay. A total of 30 fungal isolates were subjected to molecular identification based on analysis of their ITS gene region. The isolates in the inferred phylogenetic trees were affiliated with the genus Aspergillus. Ethyl acetate and butanol crude extracts of 38.2% of the 76 isolated fungal endophytes and eight mycelia samples were screened for antibacterial activity against Staphylococcus aureus (ATCC 27853), Escherichia coli (ATCC 25922), and Pseudomonas aeruginosa (ATCC 25923) using the disc diffusion method. A. marina and R. mucronata harbored the most fungal endophytes that showed the highest antibacterial activity. Seven fungal broth extracts exhibited higher antibacterial activities against the tested microorganisms than the positive control. The minimum inhibitory concentration (MIC) activity for the isolates demonstrated that the ethyl acetate extract of a root endophytic fungal isolate (RC6) (3.31 ± 0.01) of A. marina is a strong inhibitor since it showed significantly lower MIC activity compared to the positive control (3.84 ± 0.00) against Pseudomonas aeruginosa (P < 0.05). Therefore, this study confirms that mangrove species harbor fungal isolates that have antibacterial activity and hence could serve as a novel source of antibiotics. It is recommended that the pure compounds from these extracts be isolated for further bioactivity tests and structural elucidation for consideration as lead molecules in drug discovery. In addition, the genes responsible for the enhanced bioactivity in these isolates can be characterized and bioengineered for pharmaceutical application.
- 1 January 2024
- Published by Wiley in International Journal of Microbiology
- Vol. 2024 (1) , 1261721
Open AccessMolecular Characterization and Antibacterial Potential of Endophytic Fungal Isolates from Selected Mangroves along the Coastline of Kenya
The increasing emergence and re‐emergence of resistant pathogenic microbes causes a health threat to the human population. Scientists have been striving to find novel bioactive compounds and drugs to overcome these obstacles. This study aimed to characterize mangrove endophytic fungi and evaluate their antibacterial activity. Heritiera littoralis, Rhizophora mucronata, Bruguiera gymnorrhiza, Avicennia marina, and Xylocarpus granatum species were collected from Tudor Creek, Mida Creek, and Gazi Bay. A total of 30 fungal isolates were subjected to molecular identification based on analysis of their ITS gene region. The isolates in the inferred phylogenetic trees were affiliated with the genus Aspergillus. Ethyl acetate and butanol crude extracts of 38.2% of the 76 isolated fungal endophytes and eight mycelia samples were screened for antibacterial activity against Staphylococcus aureus (ATCC 27853), Escherichia coli (ATCC 25922), and Pseudomonas aeruginosa (ATCC 25923) using the disc diffusion method. A. marina and R. mucronata harbored the most fungal endophytes that showed the highest antibacterial activity. Seven fungal broth extracts exhibited higher antibacterial activities against the tested microorganisms than the positive control. The minimum inhibitory concentration (MIC) activity for the isolates demonstrated that the ethyl acetate extract of a root endophytic fungal isolate (RC6) (3.31 ± 0.01) of A. marina is a strong inhibitor since it showed significantly lower MIC activity compared to the positive control (3.84 ± 0.00) against Pseudomonas aeruginosa (P < 0.05). Therefore, this study confirms that mangrove species harbor fungal isolates that have antibacterial activity and hence could serve as a novel source of antibiotics. It is recommended that the pure compounds from these extracts be isolated for further bioactivity tests and structural elucidation for consideration as lead molecules in drug discovery. In addition, the genes responsible for the enhanced bioactivity in these isolates can be characterized and bioengineered for pharmaceutical application.